SCHEMBL6498085

SCHEMBL6498085

COc1cc(C2(OC)COc3cc(O)ccc3C2=O)ccc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.48
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
USP2 O75604 2/20 0.44
MAPT P10636 2/20 0.44
POLB P06746 2/20 0.44
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
RECQL P46063 1/20 0.44
RAB9A P51151 1/20 0.44
MAOB P27338 2/20 0.42
CES2 O00748 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
MIF P14174 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28636824 0.82 MIF (0.41) PTPN1MEN1KMT2AMAPTKDM4E
SCHEMBL29099779 0.80 PTPN1 (0.48) PTPN1MEN1KMT2AUSP2MAPT
SCHEMBL28316491 0.78 PTPN1 (0.48) PTPN1MEN1KMT2AUSP2MAPT
SCHEMBL571507 0.78 PTPN1 (0.45) PTPN1MEN1KMT2AMAPTPOLB
SCHEMBL28557922 0.74 MAOB (0.46) PTPN1KMT2APOLBRECQLMAOB
SCHEMBL3937086 0.72 MAOA (0.41) MEN1KMT2AMAPTPOLBNPC1
SCHEMBL29099783 0.71 PTPN1 (0.53) PTPN1KMT2APOLBRECQLMAOB
SCHEMBL5855134 0.70 KDM4E (0.46) PTPN1MAPTKDM4EMAOBALDH1A1
SCHEMBL1500180 0.69 MAOB (0.50) PTPN1MAPTKDM4EMAOBALDH1A1
SCHEMBL30251200 0.69 MAOB (0.50) PTPN1MAPTKDM4EMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143588-A1 Production of isoflavone derivatives NOVOGEN RESEARCH PTY LTD. 2005-06-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143588-A1 Production of isoflavone derivatives CYP51A1, EGLN2, EGLN3 PTPN1 4603/4885MEN1 1170/4885KMT2A 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.